REVERSIBILITY OF EXOGENOUS CORTICOSTEROID-INDUCED BONE LOSS

被引:0
|
作者
RIZZATO, G [1 ]
MONTEMURRO, L [1 ]
机构
[1] NIGUARDA HOSP, SARCOID CLIN, MILAN, ITALY
关键词
BONE MINERAL CONTENT; CORTICOSTEROID-INDUCED OSTEOPOROSIS; OSTEOPENIA; SARCOIDOSIS;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Osteoporosis is not usually considered to be reversible, as it is a consequence of the ageing process. However, an improvement of bone mineral density after successful surgery in Cushing's syndrome has been shown in several reports. The question of reversibility of exogenous corticosteroid-induced osteoporosis is, as vet, unanswered, possibly because of the difficulty in discontinuing steroids after long-term use. We describe six patients, all under 45 yrs of age, with chronic long-standing sarcoidosis, in whom long-term prednisone therapy resulted in 15+/-7% bone loss, as evaluated by quantitative computed tomography. This side-effect appeared fully reversible after prednisone withdrawal. This report of the reversibility of exogenous corticosteroid-induced bone loss needs confirmation in elderly people, where the capacity for recovery of bone mass could be reduced. Such potential for recovery may have implications for the pattern of use of corticosteroids.
引用
收藏
页码:116 / 119
页数:4
相关论文
共 50 条
  • [21] Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerin in male rats
    Wimalawansa, SJ
    Chapa, MT
    Yallampalli, C
    Zhang, R
    Simmons, DJ
    BONE, 1997, 21 (03) : 275 - 280
  • [22] Risedronate prevents corticosteroid-induced bone loss and decreases the risk of vertebral fractures.
    Cohen, S
    Levy, R
    Keller, M
    Sewell, KL
    Boling, E
    Eusebio, R
    Sod, E
    Chines, A
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S137 - S137
  • [23] CYCLICAL ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSS IN PRIMARY BILIARY-CIRRHOSIS
    WOLFHAGEN, FHJ
    DENOUDEN, JW
    VANBUUREN, HR
    VANLEEUWEN, JPTM
    SCHALM, SW
    POLS, HAP
    GASTROENTEROLOGY, 1995, 108 (04) : A1199 - A1199
  • [24] CORRELATION BETWEEN DXA BONE MINERAL DENSITY MEASUREMENTS AND QUS VARIABLES IN CORTICOSTEROID-INDUCED BONE LOSS
    Sindel, D.
    Oral, A.
    Ketenci, A.
    Kursuz, P.
    Aydin, T.
    Sakar, F. N. Kesiktas
    Yaliman, A.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : 682 - 682
  • [25] THICK FILAMENT (MYOSIN) LOSS IN CORTICOSTEROID-INDUCED MYOPATHY
    DANON, MJ
    SINGH, BM
    MARKS, S
    PETERSONMARSHALL, B
    NEUROLOGY, 1994, 44 (04) : A197 - A197
  • [26] The usefulness of bone ultrasonography in the assessment of corticosteroid-induced osteoporosis
    Cepollaro, C
    Gonnelli, S
    Montagnani, A
    Bruni, D
    Rossi, B
    Mangeri, M
    Breschi, M
    Caffarelli, C
    Gennari, C
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S113 - S113
  • [27] Bone histomorphometry in untreated and treated corticosteroid-induced osteoporosis
    Chavassieux, PM
    Meunier, PJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (05) : 938 - 938
  • [28] A multidisciplinary renal clinic for corticosteroid-induced bone disease
    Joy, MS
    Neyhart, CD
    Dooley, MA
    PHARMACOTHERAPY, 2000, 20 (02): : 206 - 216
  • [29] Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease
    Kikuchi, Yuichi
    Imakiire, Toshihiko
    Yamada, Muneharu
    Saigusa, Takamitsu
    Hyodo, Toshitake
    Kushiyama, Taketoshi
    Higashi, Kelshi
    Hyodo, Naomi
    Yamamoto, Kojiro
    Suzuki, Shigenobu
    Miura, Soichiro
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (06) : 1593 - 1600
  • [30] ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS FROM LUMBAR SPINE BUT NOT FROM NECK OF FEMUR
    SKINGLE, SJ
    CRISP, AJ
    CALCIFIED TISSUE INTERNATIONAL, 1994, 54 (04) : 353 - 353